Clinical Study
Cushing’s Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation
Table 1
Basic pre- and postoperative characteristics of the study group.
| | Age1 (years) | 36.1 ± 13.5 | | Males, (%) | 6 (21.4%) | | BMI1 (kg/m2) | 29.6 ± 5.8 | | Preoperative plasma ACTH2 (pg/mL) | 86.0 (62.0–137.0) | | Preoperative serum cortisol1 (µg/dL) | 26.7 ± 6.9 | | Serum cortisol after HDDST2 (µg/dL) | 3.9 (2.2–10.0) | | Initial (1st) TSS, (%) | 21 (75.0%) | | Tumor size, (%) | | | Microadenoma | 23 (82.1%) | | Macroadenoma | 5 (17.9%) | | Immunohistochemical confirmation of corticotroph tumor, (%) | 21 (75%) | Nadir serum cortisol2
on 1st or 2nd postoperative day (µg/dL) | 2.3 (1.2–8.2) |
|
|
Mean ± SD, 2median (interquartile range).
|
